Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monia Guidi

Showing results (61-70 of 107) with videos related to

Pageof 11
Sort By:
Antiviral Therapy|July 18, 2014
Vitamin D time profile based on the contribution of non-genetic and genetic factors in HIV-infected individuals of European ancestryMonia Guidi, Giuseppe Foletti, Paul McLaren, et al.
Basic & Clinical Pharmacology & Toxicology|November 5, 2024
Population pharmacokinetic modelling of cetirizine concentrations in human breast milk-A contribution from the ConcePTION projectErik Melander, Elisabet I Nielsen, Annika Lindqvist, et al.
Therapeutic Drug Monitoring|May 17, 2014
Erlotinib: another candidate for the therapeutic drug monitoring of targeted therapy of cancer? A pharmacokinetic and pharmacodynamic systematic review of literatureEmilie Petit-Jean, Thierry Buclin, Monia Guidi, et al.
Open Forum Infectious Diseases|January 8, 2020
Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIVPerrine Courlet, Françoise Livio, Monia Guidi, et al.
British Journal of Clinical Pharmacology|May 31, 2019
Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug-drug interactions and probability of target attainmentPerrine Courlet, Monia Guidi, Anaïs Glatard, et al.
Journal of Chromatography. A|December 3, 2014
High-throughput hydrophilic interaction chromatography coupled to tandem mass spectrometry for the optimized quantification of the anti-Gram-negatives antibiotic colistin A/B and its pro-drug colistimethateThomas Mercier, Fréderic Tissot, Céline Gardiol, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 3, 2023
Safety of medicines during breastfeeding - from case report to modeling: a contribution from the ConcePTION projectEvelina Cardoso, Monia Guidi, Nina Nauwelaerts, et al.
Cancers|June 27, 2024
Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies StudyAnne Ravix, Carole Bandiera, Evelina Cardoso, et al.
Clinical Pharmacokinetics|October 30, 2020
Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIVPerrine Courlet, Monia Guidi, Susana Alves Saldanha, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2025
Piperacillin dosing in pediatric patients and augmented renal clearance: are current guidelines sufficient to achieve therapeutic concentration coverage?Anne Ravix, Ermindo Roberto Di Paolo, Kim Dao, et al.
Pageof 11

Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Antiviral Therapy|July 18, 2014
Vitamin D time profile based on the contribution of non-genetic and genetic factors in HIV-infected individuals of European ancestryMonia Guidi, Giuseppe Foletti, Paul McLaren, et al.
Basic & Clinical Pharmacology & Toxicology|November 5, 2024
Population pharmacokinetic modelling of cetirizine concentrations in human breast milk-A contribution from the ConcePTION projectErik Melander, Elisabet I Nielsen, Annika Lindqvist, et al.
Therapeutic Drug Monitoring|May 17, 2014
Erlotinib: another candidate for the therapeutic drug monitoring of targeted therapy of cancer? A pharmacokinetic and pharmacodynamic systematic review of literatureEmilie Petit-Jean, Thierry Buclin, Monia Guidi, et al.
Open Forum Infectious Diseases|January 8, 2020
Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIVPerrine Courlet, Françoise Livio, Monia Guidi, et al.
British Journal of Clinical Pharmacology|May 31, 2019
Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug-drug interactions and probability of target attainmentPerrine Courlet, Monia Guidi, Anaïs Glatard, et al.
Journal of Chromatography. A|December 3, 2014
High-throughput hydrophilic interaction chromatography coupled to tandem mass spectrometry for the optimized quantification of the anti-Gram-negatives antibiotic colistin A/B and its pro-drug colistimethateThomas Mercier, Fréderic Tissot, Céline Gardiol, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 3, 2023
Safety of medicines during breastfeeding - from case report to modeling: a contribution from the ConcePTION projectEvelina Cardoso, Monia Guidi, Nina Nauwelaerts, et al.
Cancers|June 27, 2024
Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies StudyAnne Ravix, Carole Bandiera, Evelina Cardoso, et al.
Clinical Pharmacokinetics|October 30, 2020
Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIVPerrine Courlet, Monia Guidi, Susana Alves Saldanha, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2025
Piperacillin dosing in pediatric patients and augmented renal clearance: are current guidelines sufficient to achieve therapeutic concentration coverage?Anne Ravix, Ermindo Roberto Di Paolo, Kim Dao, et al.
Pageof 11